Offer Your Patients Non-Surgical Keloid Treatment

If you have patients with keloid scars on their chest, back, shoulders, earlobes, or face, you know and understand just how frustrating, annoying, and embarrassing those keloid scars can be. They’re itchy and sometimes quite painful, interrupting and causing issues for patients in their daily lives. Most of the 18 million people suffering are not […]

How to Get Rid of a Keloid Scar

If you have keloid scars on your skin, we understand just how frustrating, annoying, and sometimes embarrassing this can be. Keloid scars can be painful and itchy, varying in degrees of sensation from person-to-person, interrupting and causing problems in your daily life. Unfortunately, not even half of the millions of people suffering from keloid scars […]

Medical device company taps into 1.4 billion-person market with deal in China

Boca Raton medical device maker Sensus Healthcare has been cleared to expand operations in China, bringing its skin-treatment technology to a country with more than 1.4 billion people. Sensus Healthcare (NASDAQ: SRTS) has made a name for itself in the medical community with the SRT-100, a device sold to dermatology practices which non-invasively treats skin conditions, including keloids, […]

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]